Prevention of cytomegalovirus disease in heart transplant recipients by prophylaxis with cytomegalovirus hyperimmune globulin plus oral acyclovir.
Eisenmann
D
D
Department of Thoracic and Cardiovascular Surgery, Fulda Medical Center, Pacelliallee, FRG.
Knipp
H
H
Laube
H
H
Stegmann
T
T
D000212:Acyclovir / Q000627:therapeutic use*; D001381:Azepines / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control*; D016027:Heart Transplantation; D006801:Humans; D007106:Immune Sera; D007116:Immunization, Passive; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; D011183:Postoperative Complications / Q000517:prevention & control
D001381:Azepines; D007106:Immune Sera; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; C065458:A85 4777; C045781:cytomegalovirus-specific hyperimmune globulin; D000212:Acyclovir